Search
for
Sort by
Research 151–180 of 1000+
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome
- Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age
- Microglia: sculptors of the polycystic ovary syndrome (PCOS)-like brain?
- Androgen Action in the Ovary
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome
- Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
- Chemical Characterization and Ameliorating Effect of Centratherum anthelminticum Extract against Polycystic Ovary Syndrome in Wistar Rats
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Lean Women with Polycystic Ovary Syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Evaluating combined therapy with myoinositol and D-chiro-inositol in infertility management across PCOS phenotypes: a comprehensive retrospective data analysis
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Acupuncture improves anxiety and depression in patients with polycystic ovary syndrome: a systematic evaluation and meta-analysis
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Can serum vaspin levels predict clomiphene resistance in infertile women with PCOS?
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- Factors associated with early-onset androgenetic alopecia: A scoping review
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Obesity and polycystic ovary syndrome
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review